Figure 9

The RMSD analysis results for the variations of moving and initial drug-target complexes with 100Â ns based MD simulations. (a) represented the RMSD with proposed top ranked two receptors (TLR2, USP53) and (b) represented the RMSD with top ranked two independent receptors (IRF7, STAT1).